News

Equip I acquires Cure Media

Cure is the leading influencer marketing platform in the Nordics, with offices in Stockholm, London and Berlin. With its superior go-to-market model, data-driven approach and strong influencer expertise, Cure enables brands to effectively target and engage with consumers. A performance-focused, commercial culture with passionate employees combined with a proprietary tech platform enables the company to deliver superior value for its  customers.  Read more

Intera II to exit Renta Group to IK Partners

Intera Partners (“Intera”) is pleased to announce that Intera Fund II Ky and Intera Fund III Ky have signed an agreement to sell Renta Group Oy (“Renta Group”, “Renta” or “the Company”) to IK Partners (“IK”). Management and employees will be reinvesting alongside IK. Financial terms of the transaction are not disclosed.  Renta Group is […] Read more

Norva24, a portfolio company of Valedo II, has announced that it is planning an IPO and listing on Nasdaq Stockholm

Norva24 Group AB (publ) (“Norva24” or the ”Company”), the leading Northern European1 player in the mission critical underground infrastructure maintenance (“UIM”) industry, announces its intention to launch an initial public offering of its shares (the “Offering”) and to list its shares on Nasdaq Stockholm (the “IPO”). Norva24 has a strong acquisition track record, having completed 32 […] Read more

Lennart Svantesson will step down as CEO of NAXS AB

After more than 10 years as CEO of NAXS AB, Lennart Svantesson has decided to leave his position with the company. He will remain as CEO until a successor is appointed. The board of NAXS AB thanks him for his long history of service to NAXS. Contact information: Lennart Svantesson, CEO Telephone: +46 73 311 […] Read more

NAXS Interim financial report January-September 2021

Nine months 2021 Net profit for the nine-month period amounted to MSEK 107.7 (-6.0). Earnings per share amounted to SEK 9.66 (-0.54). Net asset value amounted to MSEK 764 (SEK 68,49 per share) at September 30, 2021, compared to MSEK 679 (SEK 60.87 per share) at December 31, 2020. Net cash amounted to MSEK 265 […] Read more

Nordic Capital CV1 and Avista Capital Partners to sell Acino, a leader in advanced drug delivery technologies, to ADQ

Leading healthcare investors Nordic Capital (through Nordic Capital CV1) and Avista Capital Partners (“Avista Capital”) today announced that they have entered into a definitive agreement to sell Acino (“Acino” or “the Company”), a Swiss pharmaceutical company headquartered in Zurich with a global platform that promotes affordable healthcare in key emerging markets through contract manufacturing and out-licensing.  The […] Read more

Inovalon to be acquired by equity consortium led by Nordic Capital including Insight Partners for $7.3 billion

Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it has entered into a definitive agreement to be acquired by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and Chief Executive Officer Keith Dunleavy, M.D. and certain Class […] Read more